Women's Mental Health Psychiatrist | Hilton Head | Farkas
Reproductive Psychiatry

Women's
Mental Health

Some depression and anxiety tracks with the reproductive cycle — premenstrual, perinatal, postpartum, perimenopausal. When symptoms are timed to a hormonal event, that timing is diagnostic information, and it changes what should be prescribed.

⏱
30–60 min evaluation
🧠
MD/PhD neuroscience
💳
Aetna & Cigna
💻
SC · NY telehealth
When to see Dr. Farkas
Mood symptoms that arrive at a predictable point in your cycle
Pregnant, postpartum, or planning — and unsure what to do about a medication
Depression or anxiety that started or worsened in perimenopause
Told it's "just hormones" while nothing has actually changed
An antidepressant that has never quite held through a reproductive transition
📅 Request an appointment → 📞 917-267-9678 ✉ hello@pearlbh.com
Understanding Women's Mental Health

What is women's mental health care?

Quick answer

Women's mental health care treats psychiatric conditions linked to reproductive events — PMDD, perinatal and postpartum depression and anxiety, and perimenopausal mood changes — plus the sex differences in medication response and side-effect burden that general psychiatric care often skips. Dr. Farkas provides hormone-informed prescribing and coordinates with gynecology when hormone therapy and psychiatric treatment overlap.

Hormonal transitions don't cause depression in everyone. They destabilize mood in people who are sensitive to the shift — and that sensitivity is a clinical feature worth identifying, because it predicts what will happen at the next transition. A patient whose mood broke down premenstrually in her twenties, postpartum in her thirties, and again in perimenopause is not having three unrelated episodes.

Depression is diagnosed more often in women than in men. NIMH reports a past-year major depressive episode in 10.3% of adult women compared with 6.2% of adult men. NIMH also identifies three depressions that are specifically timed to hormone change: perinatal depression, premenstrual dysphoric disorder, and perimenopausal depression. The postpartum period is the most-studied of the three — CDC's Pregnancy Risk Assessment Monitoring System has found that roughly 1 in 8 women report symptoms of depression after giving birth.

The sorting matters as much here as anywhere in psychiatry. PMDD is not premenstrual worsening of an existing depression, and the two are managed differently. Postpartum depression is not postpartum anxiety or postpartum OCD, and none of them is bipolar disorder surfacing after delivery — which is why ACOG recommends screening for bipolar disorder before starting an antidepressant. Mood symptoms in perimenopause can also be driven by thyroid disease, iron deficiency, or sleep fragmented by night sweats, each of which has its own treatment.

Dr. Farkas brings MD/PhD neuroscience training, NIH research center experience, and board-certified psychiatric practice to that work. Her 30–60 minute evaluations are built to place symptoms on a reproductive timeline before anything is prescribed against them.

Conditions treated

Premenstrual dysphoric disorder (PMDD)Severe irritability, depressed mood, and anxiety confined to the luteal phase, lifting shortly after menses — diagnosed with prospective tracking, not recall
Perinatal depression and anxietyDepression or anxiety that begins or worsens during pregnancy, where the risk of untreated illness has to be weighed alongside the risk of treatment
Postpartum depression, anxiety, and OCDIncludes intrusive thoughts about harm coming to the baby — distressing, common, and not the same as intent, though they deserve prompt evaluation
Perimenopausal depressionNew or recurrent depression during the menopause transition, often with sleep disruption, irritability, and cognitive complaints that get dismissed as ordinary aging
Preconception and lactation planningDeciding what to continue, change, or stop before conception or while breastfeeding — planned in advance rather than improvised after a positive test
Depression, anxiety, and ADHD across the lifespanGeneral psychiatric care that accounts for hormonal state, contraception, fertility treatment, and menopause therapy rather than treating them as background detail

Conditions as classified in the DSM-5-TR. This page is educational and is not a diagnostic tool.

Treatment Approach

How Dr. Farkas treats women's mental health conditions

Evidence-based, neurobiologically informed, and organized around where you are in the reproductive timeline — not around a protocol that ignores it.

📆
Symptoms Placed on a Timeline
Mood history is mapped against cycles, pregnancies, postpartum periods, contraception changes, and the menopause transition. A pattern that repeats at hormonal transitions points somewhere different than one that doesn't.
📋
Prospective Tracking for PMDD
A PMDD diagnosis requires daily symptom ratings across at least two cycles. Retrospective recall reliably overestimates the premenstrual pattern and misses the underlying disorder that worsens premenstrually — a different condition with different treatment.
⚖️
Honest Pregnancy Risk–Benefit
Neither treatment nor untreated illness is risk-free in pregnancy, and pretending otherwise helps no one. Decisions follow ACOG's clinical practice guideline, are made with you, and are documented so the plan holds when you're seen elsewhere.
🤝
Coordination With Your OB/GYN
When hormonal contraception, fertility treatment, or menopausal hormone therapy overlaps with psychiatric medication, the two plans have to be built together. Dr. Farkas communicates directly with the treating gynecologist.
🩺
Medical Contributors Ruled Out
Thyroid dysfunction, iron deficiency anemia, vitamin D deficiency, sleep apnea, and sleep fragmented by vasomotor symptoms all produce mood and cognitive symptoms. These are checked rather than assumed away as hormonal.
📊
Measurement-Based Tracking
Standardized measures — PHQ-9, GAD-7, and the Edinburgh Postnatal Depression Scale in the perinatal period — are repeated at follow-up so adjustments are driven by data instead of impression.
Patient discussing mood and hormonal symptoms with a psychiatrist
New patient evaluations run 30–60 minutes, in person in Hilton Head Island, SC or by telehealth in SC and NY.
Getting Started

What to expect from your first appointment

A new patient evaluation with Dr. Farkas runs 30–60 minutes. It covers your psychiatric and medical history, your reproductive history, every medication tried and how each one went, and how symptoms have lined up with cycles, pregnancies, and transitions over time.

You'll leave with a specific diagnosis explained in plain terms, a treatment plan you understand and agree with, and a follow-up already scheduled. If a PMDD diagnosis is on the table, you'll leave with a tracking method and a return date. Telehealth is available throughout South Carolina and New York. In-person appointments are available at the Hilton Head Island, SC office.

Comprehensive evaluation — not a 15-minute intake
Reproductive and hormonal history taken as clinical data
Full review of prior diagnoses and medication history
Medical contributors screened rather than assumed hormonal
Coordination with your OB/GYN where treatment overlaps
Baseline symptom measurement so progress is visible
If you're in crisis

Call or text 988 (Suicide & Crisis Lifeline). Text HOME to 741741 for the Crisis Text Line. The National Maternal Mental Health Hotline is available 24/7 at 1-833-852-6262. Call 911 or go to your nearest emergency room if you are in immediate danger.

Medical disclaimer: This page is for educational purposes and does not constitute medical advice. No doctor–patient relationship is established through website use. Individual results vary; no specific outcome is guaranteed. Decisions about psychiatric medication during pregnancy or lactation require individualized evaluation and should not be made on the basis of website content. Telehealth visits are conducted on a HIPAA-compliant platform. Gabriella I. Farkas, MD PhD, is a board-certified psychiatrist licensed in South Carolina and New York.

Ready for care that accounts
for the whole picture?

30–60 minutes. A specific diagnosis. A plan built around where you actually are — not around a protocol that ignores it.

Anxiety Management | MD/PhD Psychiatrist | Dr. Farkas
Quick Answer

Women's mental health care treats psychiatric conditions linked to reproductive events — PMDD, perinatal and postpartum depression and anxiety, and perimenopausal mood changes — plus the sex differences in medication response and side-effect burden that general psychiatric care often skips. Dr. Farkas provides hormone-informed prescribing and coordinates with gynecology when hormone therapy and psychiatric treatment overlap.

Key Takeaways

  • Women's mental health care treats conditions tied to reproductive events, including PMDD, perinatal depression and anxiety, and perimenopausal mood changes.
  • It also accounts for sex differences in how medications work and in side effects.
  • Prescribing is hormone-informed.
  • Care is coordinated with gynecology when hormone therapy and psychiatric medication overlap.
Medically reviewed by Gabriella I. Farkas, MD PhD — Board-Certified Psychiatrist · Reviewed 2026-07-09 · MD/PhD Neuroscience · Zucker Hillside NIH Research Center
Related topics on this page: anxiety psychiatrist · SSRI for anxiety · non-addictive anxiety treatment · chronic anxiety care

Frequently Asked Questions

What's the safest medication for chronic anxiety?

SSRIs and SNRIs have the strongest long-term safety and efficacy evidence. Buspirone is a non-sedating, non-addictive option for generalized anxiety. Benzodiazepines are effective short-term but carry dependence risk and are avoided as chronic treatment where possible.

How is anxiety diagnosed?

Diagnosis requires structured clinical interview covering symptom pattern, duration, functional impairment, and rule-outs (thyroid dysfunction, cardiac arrhythmia, substance use, medications). Validated tools (GAD-7, PSWQ) supplement clinical assessment.

Can I stop anxiety medication once I feel better?

Discontinuation is planned, not abrupt. Most SSRIs require slow tapering to avoid discontinuation syndrome. Dr. Farkas typically continues for 9–12 months after remission before considering taper, timing to a low-stress period.

Related pages

Women's Mental Health | Reproductive Psychiatrist | Dr. Farkas
Quick Answer

Women's mental health encompasses reproductive-cycle-linked conditions — PMDD, perinatal mood and anxiety disorders, perimenopausal depression — as well as sex differences in medication response and side-effect profiles. Dr. Farkas provides hormone-informed prescribing and coordinates with gynecology when hormone therapy overlaps with psychiatric care.

Medically reviewed by Gabriella I. Farkas, MD PhD — Board-Certified Psychiatrist · Reviewed 2026-07-09 · MD/PhD Neuroscience · Zucker Hillside NIH Research Center
Related topics on this page: womens psychiatry care · hormone-informed psychiatric care · reproductive psychiatry · female-specific mental health

Frequently Asked Questions

What is reproductive psychiatry?

Reproductive psychiatry is a subspecialty focused on psychiatric care across the female reproductive lifespan — menstrual cycle, pregnancy, postpartum, perimenopause, menopause. Care accounts for hormonal contributions, medication safety during pregnancy and lactation, and hormone-medication interactions.

Are psychiatric medications safe during pregnancy?

Many medications can be used with careful risk-benefit analysis. Untreated maternal psychiatric illness carries substantial risks — preterm birth, low birth weight, postpartum illness, impaired infant development. Decisions are individualized using the latest data (MotherToBaby, LactMed) and coordinated with obstetrics.

Are there sex differences in medication response?

Yes — women may experience different metabolism (particularly with CYP3A4 substrates), higher rates of certain side effects, and hormone-modulated response variability. Dr. Farkas accounts for these in dosing and monitoring.

Related pages

Women’s Mental Health

Women’s mental health encompasses unique psychiatric challenges from hormonal transitions, reproductive events, and gender-specific risk factors throughout a woman’s life—PMDD, perinatal/postpartum depression, perimenopausal mood changes, and higher prevalence of anxiety and depression. 

Women's Mental Health | Treatment & Care | Dr. Gabriella Farkas

Understanding Women's Mental Health

Women's mental health involves unique psychiatric challenges connected to hormonal transitions and reproductive life events. Comprehensive, life-stage appropriate care recognizes these interconnections while addressing individual psychiatric needs.

Common Symptoms

Emotional & Psychological

  • Mood changes related to hormonal shifts
  • Depression or anxiety with hormonal triggers
  • Emotional reactivity and sensitivity
  • Difficulty managing stress and emotions

Physical & Behavioral

  • Sleep disturbances and insomnia
  • Energy level fluctuations
  • Appetite changes and weight fluctuations
  • Physical symptoms related to hormonal changes

How Women's Mental Health Needs are Assessed

Women's mental health evaluation requires understanding of hormonal contributions to psychiatric symptoms and assessment across life stages. Dr. Farkas conducts comprehensive evaluation integrating hormonal context with psychiatric assessment.

Why Choose Dr. Farkas for Women's Mental Health

Hormone-Psychiatry Expertise

Specialized understanding of how hormonal changes affect mood across all life stages and reproductive transitions.

Life-Stage Approach

Dynamic, evolving treatment addressing psychiatric needs at different reproductive life stages and transitions.

Perinatal Specialization

Expert expertise in pregnancy, breastfeeding, and postpartum psychiatric medication safety and management.

Evidence-Based Care

Treatment grounded in latest research on women's mental health and hormonal psychiatry across life stages.

Ready for Women's Mental Health Treatment?

Expert psychiatric care addresses women's unique mental health needs. Dr. Gabriella Farkas provides specialized, life-stage appropriate treatment.

Call (917) 267-9678 for Your Consultation

Next Steps

Schedule Your Evaluation

Contact Dr. Farkas to schedule your comprehensive psychiatric evaluation. New patient appointments typically available within 2-4 weeks. During your first appointment, Dr. Farkas will:

  • Assess psychiatric symptoms within hormonal and life-stage context
  • Perform comprehensive psychiatric evaluation
  • Evaluate hormonal contributions to mental health
  • Develop personalized treatment plan for your life stage

Treatment Options

Based on your evaluation, Dr. Farkas discusses treatment options accounting for hormonal status, reproductive goals, and psychiatric needs across your life stages.

Ongoing Care

Regular appointments provide life-stage appropriate psychiatric care, adjust treatment as hormonal status and life circumstances change, and provide continued support throughout all reproductive life stages.

Privacy & Confidentiality: Dr. Farkas's practice is fully HIPAA-compliant. Your health information is protected with the highest standards of confidentiality and security.

Vital Voice Online

Schedule a Consultation

Fill out the form below and we'll get back to you within 24 hours.

Request Sent!

We've received your request and will be in touch within 24 hours.

Something went wrong